Skip to search formSkip to main contentSkip to account menu

ERCC1 Ag:PrThr:Pt:Tiss:Ord:Immune stain

Known as: ERCC1 Ag:PrThr:Moment:Weefsel en uitstrijkjes:Ordinaal:Immunokleuring, ERCC1 antigène [Arbitraire/Volume] Tissu ; Qualitatif ; Coloration immune, ERCC1 ??:PrThr:??????:??:???:????????????????????? ??????? 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Background Malignant mesothelioma (MM) is a rare aggressive tumour of mesothelium caused by asbestos exposure. It has… 
2018
2018
Background There has been little progress toward personalized therapy for patients with metastatic colorectal cancer (mCRC). TYMS… 
2017
2017
A total of 149 lung cancer patients were recruited to receive intensity modulated radiation therapy (IMRT). The association of… 
2013
2013
Background Benzo[a]pyrene(B[a]P), and its ultimate metabolite Benzo[a]pyrene 7,8-diol 9,10-epoxide (BPDE), are classic DNA… 
2013
2013
Objectives Although it does not alter the ERCC1 phenotype, the ERCC1 500C>T (rs11615) polymorphism has undergone a myriad of… 
2013
2013
Background Cervical cancer is the second most common cancer in women worldwide. A large number of young sexually active women get… 
2012
2012
Benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (BPDE), a metabolite of Benzo[a]pyrene (B[a]P), is a high-risk factor for development… 
2011
2011
Received: November 30, 2009; Accepted: February 16, 2010 Corresponding author: Ekrem Cengiz Seyhan, MD. Ressam Salihermez sok… 
2011
2011
目的:探讨ERCC1 β-tubulin Ⅲ与ⅢA-N2期非小细胞肺癌中的表达与辅助化疗药物铂类、紫杉类的相关性,为非小细胞肺癌个体化辅助化疗提供依据。方法:应用免疫组化方法检测ERCCl、β-tubulin Ⅲ在89例手术完全切除并行含铂辅助化疗的ⅢA… 
2010
2010
5101 Background: Platinum and taxane are active drugs in the treatment of ovarian cancer.The polymorphism C8092A of ERCC1 is…